NeuroPace (NPCE) Amortizatization of Intangibles (2022 - 2026)
NeuroPace (NPCE) recorded quarterly Amortizatization of Intangibles of $453000.0 in Q1 2026, up 2.49% quarter-over-quarter from $442000.0 in Q4 2025, and up 9.69% on a YoY basis from $413000.0 in Q1 2025.
NeuroPace (NPCE) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
NeuroPace's Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $453000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 9.69% year-over-year to $453000.0; the TTM figure through Mar 2026 stood at $1.8 million (up 9.58% YoY), while the FY2025 annual figure was $1.7 million, up 9.48% from the prior year.
- Amortizatization of Intangibles was $453000.0 for Q1 2026 at NeuroPace, up from $442000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $698000.0 in Q4 2022 to a low of $347000.0 in Q1 2023.
- Historically, Amortizatization of Intangibles has averaged $463411.8 across 5 years, with a median of $413000.0 in 2025.
- The sharpest annual moves came in 2023 and 2026: Amortizatization of Intangibles slumped 48.36% in 2023, then advanced 9.69% in 2026.
- A 5-year view of Amortizatization of Intangibles shows it stood at $698000.0 in 2022, then slumped by 47.13% to $369000.0 in 2023, then increased by 9.21% to $403000.0 in 2024, then rose by 9.68% to $442000.0 in 2025, then rose by 2.49% to $453000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $453000.0 (Q1 2026), $442000.0 (Q4 2025), and $433000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 422.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 180.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 6.50 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 75.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | NeuroPace | 534.75 Mn | 480.77 Mn | 18.05 Mn | 453,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 453,000.00 |
| Mar 31, 2026 | 453,000.00 |
| Dec 31, 2025 | 442,000.00 |
| Dec 31, 2025 | 442,000.00 |
| Sep 30, 2025 | 433,000.00 |
| Sep 30, 2025 | 433,000.00 |
| Jun 30, 2025 | 422,000.00 |
| Jun 30, 2025 | 422,000.00 |
| Mar 31, 2025 | 413,000.00 |
| Mar 31, 2025 | 413,000.00 |
| Dec 31, 2024 | 403,000.00 |
| Dec 31, 2024 | 403,000.00 |
| Sep 30, 2024 | 395,000.00 |
| Sep 30, 2024 | 395,000.00 |
| Jun 30, 2024 | 386,000.00 |
| Jun 30, 2024 | 386,000.00 |
| Mar 31, 2024 | 378,000.00 |
| Mar 31, 2024 | 378,000.00 |
| Dec 31, 2023 | 369,000.00 |
| Dec 31, 2023 | 369,000.00 |